We are The Leukemia & Lymphoma Society, the largest nonprofit dedicated to creating a world without blood cancers. Since 1949, we’ve invested more than $1.3 billion in groundbreaking research, pioneering many of today’s most innovative approaches. We work tirelessly to find cures and ensure patients can access the lifesaving treatments they need. When someone experiences the fear and uncertainty of a cancer diagnosis, we provide hope, compassion, education and support. And we are making an impact in the cancer community. More than 70 years of fighting blood cancers has led us to a game changing belief. The cures for cancer are in our blood. We focus on three key areas: Research We are the largest nonprofit funder of blood cancer research. Advocacy We advocate at the state and federal level for policies to ensure blood cancer patients have access to affordable care and the most innovative therapies. Patient Support We are the leading source of free information and support for blood cancer patients, including help finding appropriate clinical trials. Within our Mission, we are committed to providing information, resources and support to those affected by blood cancers through various campaigns, including, Team in Training, Light the Night, Man & Woman of the Year, Student of the Year, Big Climb, and Hero Squad. Join us on social media: Facebook: https://www.facebook.com/LLSusa Twitter: https://twitter.com/LLSusa Instagram: @llsusa Tik Tok: @llsusa To learn more, visit http://www.lls.org
External link for The Leukemia & Lymphoma Society
The moment we’ve all been waiting for... 2025 LLS Light The Night registration is OPEN ✨ ✨ ✨ Whether you’re attending as a supporter ❤️, a survivor 🤍, or in memory of a loved one 💛 you can help bring light to the darkness of cancer. Find an event near you and register today 👉 https://bit.ly/42JSyQK
”In March 2024, during my first year of college as an international student in America, I was diagnosed with lymphoma. The diagnosis came unexpectedly during a compulsory admissions check-up, where they discovered a tumor in my chest that had grown extensively within just two months. During the diagnosis, I faced significant challenges. As an international student without insurance that covered cancer treatment, I was turned away by multiple hospitals despite offering to pay out of pocket. The rejection was devastating and overwhelming, as my status as a non-citizen made it difficult to access care, especially when I was alone. Eventually, I came across The Leukemia & Lymphoma Society (LLS), and they helped me navigate towards a resolution. I was admitted to a children’s hospital where a compassionate doctor connected me to St. Jude. From that point forward, St. Jude took over my care. I continued to receive treatment and love from the St. Jude team until I completed my treatment this October. I am now in remission. I am deeply grateful to the doctors who helped me. It was a huge shock for my parents, who were back in Africa, and I had to face much of this journey on my own. However, I was incredibly blessed to have a kind samaritan family step in. They took on a parental role, helping me navigate the healthcare system, find hospitals, and eventually settle. This experience has taught me that cancer is no joke. The near-death experience reminded me always to be grateful, to find the brighter side of life, and never to give up—because there is always someone watching over you.” Together, we can help patients with #BloodCancer, like Matilda, celebrate more birthdays and create more cherished memories. Your contribution brings us closer to making our bold goal a reality. And this #WorldCancerDay, thanks to a generous gift from The Orokawa Foundation, your donation today will be matched dollar-for-dollar up to $75,000 👉 https://bit.ly/3EnsIrA
Think of the moments that make you feel full...we want MORE of them! 💭 More belly laughs. 🤣 More bear hugs. 🧸 More candle wishes. 🎂 More sunsets. 🌅 Everyone deserves more. On #WorldCancerDay, we’re focused on the future we want to create—one where patients with #BloodCancer gain more than one million years of life by 2040. Because longer lives means more time to feel alive. ❤️🌎 Learn more 👉 https://bit.ly/40YUgwb
A huge moment at Nasdaq today—we rang the bell loud and clear for blood cancer patients! 🔔🔔 We’re not only celebrating 75 years of LLS, but in advance of World Cancer Day on 2/4, we’re ringing in our bold goal: by 2040, we’ll help blood cancer patients gain one million more years of life. More than one. Million. Years. More birthdays, more graduations, more cherished moments with family and friends—that’s what this milestone means for patients. And just like the sound of the bell, our impact will echo. For generations. The momentum is building—learn more 👉 https://bit.ly/42UZCKv
A major milestone for #BloodCancer patients! 🫶 The U.S. FDA has approved a treatment that may offer hope to some children and adults with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). This breakthrough may make stem cell transplants more accessible with fewer side effects. We’re dedicated to advancing personalized, effective treatments for all blood cancers—ensuring better options for every patient. Learn more 👉 https://bit.ly/3EhGdcf
Artificial intelligence is transforming healthcare, offering opportunities to streamline processes, enhance diagnoses, and improve patient outcomes. But it also raises critical concerns about privacy, accuracy, and equity. This topic took center stage at the ASH 2024 Clinicians in Practice luncheon, where patient perspectives highlighted the importance of trust and transparency in AI’s integration into care. Explore the benefits, challenges, and actionable insights for both patients and healthcare professionals 👉 https://bit.ly/3E8Ymc4 #ASH24
"December 9th, 2022, is a day I will never forget. I received a phone call from my wife, Stephanie, telling me that I needed to take her to the ER. She had just been diagnosed with acute myeloid leukemia (AML). My heart dropped. All I knew was that I would be right by her side. For the first 50 days of her stay in the hospital, I slept in a recliner by her side every single night. During this time, I watched my wife, best friend, and soulmate transform into the strongest human I know. Just when we thought our lives were starting to return to normal, I received the devastating news that I was diagnosed with breast cancer. It was not what we had ever expected, especially after everything Stephanie had been through. Still, she immediately stepped into the caregiver role without hesitation. I am incredibly grateful to have Stephanie by my side through everything life has thrown our way." – Amy, breast cancer survivor. "My experience with blood cancer began before my own diagnosis. In 2006, my mom was diagnosed with AML. A fungal pneumonia took her from us that same year. In 2022, I was living a life my mom would have been proud of and had married Amy, my soulmate. My doctor found something alarming—my blood counts were dangerously low. Within a few weeks, I received a call from the doctor: 'You have AML.' I hung up the phone, called my wife to come home, and we cried together, fearing the unknown ahead. That evening, I was admitted to the hospital. I spent Christmas, New Year’s, my 40th birthday, and my wedding anniversary in that hospital, fighting for my life. My wife stayed by my side every single night for 50 days. The Leukemia & Lymphoma Society (LLS) has been a lifeline. They provided financial assistance to help us manage the overwhelming costs of medical bills and offered resources that made me feel seen and supported. To anyone facing a blood cancer diagnosis, my best advice is to take it one day at a time. Stick to trusted sources like LLS. And remember: you are not alone." – Stephanie, AML survivor. Like Amy and Stephanie's love, it stands firm in sickness and in health. ❤️ It’s #NationalSpousesDay, tag your person to celebrate your love!
Dr. Stephen Oh from Washington University in St. Louis is unlocking new possibilities for treating chronic myelomonocytic leukemia (CMML). 🔓 CMML is a rare and complex blood disorder with limited treatment options, making it difficult for patients to find relief. He’s diving deep into what drives CMML’s development and progression, aiming to uncover new pathways for treatment that could lead to better options and brighter futures for patients. Get the details 👉 https://bit.ly/3Wu7QFf
What does it take to accelerate progress for acute myeloid leukemia (AML) patients? Let’s talk about it. 🗣️ Join our Therapy Acceleration Program® (TAP) team with LLS Staff and biotech partners for a live, one-hour discussion about how collaboration is moving the needle for patients on Friday, 1/31 at 12 PM EST/9 AM PST. You can expect to hear from: 🎙️ Lawrence Mayer, PhD – Celator Pharmaceuticals 🎙️ Ashley Yocum, PhD – LLS Beat AML 🎙️ Ann Cahill Collins, PA – LLS PedAL 🎙️ Stephan Braun, MD, PhD – ImCheck Therapeutics Register today 👉 https://bit.ly/3PHLwUS
The U.S. FDA has approved a new treatment option that may improve outcomes in some patients living with mantle cell lymphoma (MCL). It’s a hopeful moment for patients and their families. ❤️ “New drugs and treatment approaches are vital for people facing mantle cell lymphoma because it is an aggressive type of blood cancer that often goes into only short remissions,” says Lore Gruenbaum, Ph.D., LLS Chief Scientific Officer. “LLS is supporting multiple approaches to find even more ways to treat this insidious disease.” Find out more 👉 https://bit.ly/3PLFiTK